Clincosm LogoSign in Get a demo

Models of Auditory Hallucination

Sponsor
Yale University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04210557
Collaborator
National Institute of Mental Health (NIMH) (NIH)
100
Enrollment
1
Location
2
Arms
34.1
Anticipated Duration (Months)
2.9
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to address the shortcoming in clinical hallucination research by causally manipulating the neural loci of conditioned hallucination task behavior in-person in patients with psychosis using transcranial magnetic stimulation (TMS), tracking the impact of this manipulation on the number of times participants with hallucinations report hearing tones that were not presented. With such a causal intervention, the veracity of this explanation of hallucinations will be either validated or disconfirmed. If validated, the task can be further developed as a biomarker for predicting the hallucination onset, guiding, developing or tracking the effects of treatments for hallucinations.

Condition or Disease Intervention/Treatment Phase
  • Device: Transcranial Magnetic Stimulation (TMS)
 N/A

Detailed Description

Hallucinations are percepts without stimulus. 70% of patients with schizophrenia suffer distressing auditory hallucinations. Their mere presence increases the risk of suicide. Most reach remission with D2 dopamine receptor blocking drugs after 1 year of adherence. However, 30% of patients have intractable hallucinations, and 50% are non-adherent to their medications, commonly because of unfavorable side-effects - those intractable and non-adherent patients continue to suffer. There is a clear need for a mechanistic understanding of hallucinations as a prelude to rational treatment design.

This study provides the initial steps towards the development of an interventional biomarker for clinical hallucinations, grounded in computational neuroscience.

Computational psychiatry involves harnessing the power of computational neuroscience to address the clinical needs of those suffering from serious mental illnesses. There has been much discussion of the promise of the approach. There have been few studies thus far and they have largely involved correlative methods like functional neuroimaging. This study will address this shortcoming by causally manipulating the neural loci of computational model parameters in-person in patients with psychosis using transcranial magnetic stimulation (TMS), tracking the impact of this manipulation on behavioral task performance . With such a causal intervention, the veracity of the model's explanation of hallucinations will be either validated or disconfirmed. If validated, the model can be further developed as a biomarker for predicting the hallucination onset, guiding, developing or tracking the effects of treatments for hallucinations. If disconfirmed, the model ought to be discarded and other alternatives should be pursued.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Masking Description:
The participant, the physician administering TMS, and the research psychologist will be blind to the condition. One research assistant will be unblinded to the condition. This unblinded research assistant is responsible for setting up the active TMS coils or the sham TMS coils and determining the protocol used, to maintain the blindness of other study staff and the participant.
Primary Purpose:
Basic Science
Official Title:
Models of Auditory Hallucination
Actual Study Start Date :
Feb 27, 2020
Anticipated Primary Completion Date :
Dec 30, 2022
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: TMS to insula

This study will recruit 30 clinical voice hearers (P+H+). They will complete two parallel forms of the conditioned hallucinations task (with different visual and auditory stimuli) on two occasions, separated by a week. TMS and sham will be delivered in a randomized counterbalanced order. Hypothesis: Inhibiting the insula will decrease prior over-weighting. If this computational perturbation is responsible for conditioned hallucinations, then ameliorating it with TMS that increases insula engagement will decrease conditioned hallucination responses. Furthermore, the prior weighting parameter will be reduced following active TMS compared with sham.

Device: Transcranial Magnetic Stimulation (TMS)
Transcranial magnetic stimulation (TMS) is a noninvasive form of brain stimulation in which a changing magnetic field is used to cause electric current at a specific area of the brain through electromagnetic induction. An electric pulse generator, or stimulator, is connected to a magnetic coil, which in turn is connected to the scalp. The stimulator generates a changing electric current within the coil which induces a magnetic field; this field then causes a second inductance of inverted electric charge within the brain itself.
Other Names:
  • repetitive transcranial magnetic stimulation (rTMS)

    		•
    Experimental: TMS to cerebellum

    This study will recruit a further 70 clinical voice hearers. Again, they will complete parallel forms of the conditioned hallucinations task on two occasions, separated by a week. They will receive excitatory TMS over the cerebellum (and sham on the other occasion, in a randomized counterbalanced order). Hypotheses: Exciting the cerebellum will increase belief-updating. If poor belief-updating contributes to conditioned hallucinations, increasing cerebellum engagement should decrease conditioned hallucinations and alter the belief-updating model parameter compared with sham TMS.

    Device: Transcranial Magnetic Stimulation (TMS)
    Transcranial magnetic stimulation (TMS) is a noninvasive form of brain stimulation in which a changing magnetic field is used to cause electric current at a specific area of the brain through electromagnetic induction. An electric pulse generator, or stimulator, is connected to a magnetic coil, which in turn is connected to the scalp. The stimulator generates a changing electric current within the coil which induces a magnetic field; this field then causes a second inductance of inverted electric charge within the brain itself.
    Other Names:
  • repetitive transcranial magnetic stimulation (rTMS)

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Conditioned Hallucinations task performance [18 months]

      The primary outcome measure is the number of times participants report hearing tones that were not presented. There are 360 total trials. There are 120 no tone trials. People who hear voices typically report hearing tones on 30% of the no tone trials (approximately 36 times, as compared to 12 times in people who do not hear voices). The investigators anticipate fewer conditioned hallucinations (fewer than 36 reports of tones when none were presented) in the active TMS conditions as compared to the sham.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Aged 18 - 45 years

    • Voice hearing patients

    • Meet diagnostic criteria for DSM-V schizophrenia or schizophreniform disorder

    • Report hearing voices at least once a day

    • Score > 3 on PANSS P3 (hallucinations item)

    Exclusion Criteria:

    • DSM-V substance use disorder within the past 6 months

    • Previous head injury with neurological symptoms and/or unconsciousness

    • Intellectual disability (IQ < 70)

    • Non-English speaker

    • Contraindications for TMS, including:

    • History of seizures

    • Metallic implants

    • Pacemaker

    • Pregnancy

    • Less than 6 weeks of a stable dose of psychotropic medication(s)

    • Comorbid mood or anxiety diagnosis

    • Clinically/behaviorally instability and unable to cooperate with TMS procedures

    • Clinically significant medical condition(s)

    • Unstable medical condition(s) based on EKG, medical history, physical examination, and routine lab work

    • Personal history of stroke

    • Family history of seizures

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Connecticut Mental Health Center (CMHC) New Haven Connecticut United States 06519

    Sponsors and Collaborators

    • Yale University
    • National Institute of Mental Health (NIMH)

    Investigators

    • Principal Investigator: Philip R Corlett, PhD, Yale School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Yale University
    ClinicalTrials.gov Identifier:
    NCT04210557
    Other Study ID Numbers:
    • 2000023640
    First Posted:
    Dec 24, 2019
    Last Update Posted:
    Feb 9, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Yale University
    TMS
    Transcranial Magnetic Stimulation
    Additional relevant MeSH terms:
    Hallucinations
    Schizophrenia
    Mood Disorders
    Psychotic Disorders

    Study Results

    No Results Posted as of Feb 9, 2022